Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 303

Results For "IMA"

3524 News Found

VivaLyf Innovations to launch EzLyf, India's first non-invasive glucometer
Startup | December 30, 2021

VivaLyf Innovations to launch EzLyf, India's first non-invasive glucometer

The glucometer connects to one’s smartphone and provides actionable diagnostic information


Merck awarded €121 million contract for flow membrane production facility in Wisconsin, USA
Clinical Trials | December 30, 2021

Merck awarded €121 million contract for flow membrane production facility in Wisconsin, USA

The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness


Translumina to set up Asia's largest heart valve facility at AMTZ Vizag
News | December 29, 2021

Translumina to set up Asia's largest heart valve facility at AMTZ Vizag

The facility at the Andhra Pradesh Medtech Zone is expected to be completed by Dec 2022


Granules Inc., receives ANDA approval for prazosin hydrochloride
Drug Approval | December 28, 2021

Granules Inc., receives ANDA approval for prazosin hydrochloride

The current annual U.S. market for prazosin hydrochloride 1mg, 2mg, 5mg strengths is approximately US $ 54 million, according to IQVIA/IMS Health


RaphaCure partners with Zeebon for foraying into North East market
Clinical Trials | December 28, 2021

RaphaCure partners with Zeebon for foraying into North East market

Zeebon is the largest diagnostics services provider in North-Eastern states


Expectations and predictions for 2022
Opinion | December 28, 2021

Expectations and predictions for 2022

In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc


Trastuzumab deruxtecan type II variation application validated by EMA
Biotech | December 28, 2021

Trastuzumab deruxtecan type II variation application validated by EMA

Application based on DESTINY-Breast03 results showing Daiichi Sankyo and AstraZeneca’s trastuzumab deruxtecan reduced risk of disease progression or death by 72% versus trastuzumab emtansine (T-DM1)


India’s 1st indigenously developed protein sub-unit Covid-19 vaccine Corbevax gets nod
Drug Approval | December 28, 2021

India’s 1st indigenously developed protein sub-unit Covid-19 vaccine Corbevax gets nod

It plans to deliver over 300 million doses to the Indian government


NATCO receives approval for the drug for the treatment of Covid-19
Drug Approval | December 28, 2021

NATCO receives approval for the drug for the treatment of Covid-19

Natco Pharma has received approval for Covid 19 drug molnupiravir capsules 200 mg. for Indian market, which will be sold under brand name Molnunat


Lupin receives U.S. FDA approval for Sevelamer Carbonate
Drug Approval | December 27, 2021

Lupin receives U.S. FDA approval for Sevelamer Carbonate

This product will be manufactured at Lupin's Goa facility in India